Globus Medical (NYSE:GMED – Get Free Report) had its price objective increased by stock analysts at Truist Financial from $58.00 to $60.00 in a research report issued on Wednesday, Benzinga reports. The brokerage presently has a “hold” rating on the medical device company’s stock. Truist Financial’s target price would suggest a potential upside of 8.58% […]
Globus Medical (NYSE:GMED – Get Free Report) updated its FY24 earnings guidance on Tuesday. The company provided earnings per share guidance of $2.68 to $2.70 for the period, compared to the consensus earnings per share estimate of $2.69. The company issued revenue guidance of $2.450 billion to $2.475 billion, compared to the consensus revenue estimate […]
Globus Medical (NYSE:GMED) Issues FY 2024 Earnings Guidance theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Globus Medical (NYSE:GMED) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPS kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.